N@N

Michael Petusky Upgraded (ANIK) to Buy and Held Target at $31 on, Nov 9th, 2022

^{Published on 2024-10-28 00:02:12 - WOPRAI, Michael Petusky}
 

Michael Petusky of Barrington Research, Upgraded "Anika Therapeutics, Inc." (ANIK) to Buy and Held Target at $31 on, Nov 9th, 2022.

Michael has made no other calls on ANIK in the last 4 months.

There is 1 other peer that has a rating on ANIK. Out of the 1 peers that are also analyzing ANIK, all agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• George Sellers of "Stephens & Co." Initiated at Hold and Held Target at $26 on, Friday, October 14th, 2022

Contributing Sources

---